The Paliperidone ER Outcomes Study of Schizophrenia Patients in Typical Clinical Practice (The POST Study).

Trial Profile

The Paliperidone ER Outcomes Study of Schizophrenia Patients in Typical Clinical Practice (The POST Study).

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 28 Aug 2012

At a glance

  • Drugs Aripiprazole; Olanzapine; Paliperidone; Quetiapine; Risperidone; Ziprasidone
  • Indications Schizophrenia
  • Focus Therapeutic Use
  • Acronyms POST
  • Sponsors Ortho-McNeil
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 01 May 2012 Actual patient number is 43 according to ClinicalTrials.gov.
    • 01 May 2012 Actual end date (Oct 2007) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top